Latest total assets for EYES: $42M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), EYES shows a total assets of $42M. That compares with $29M in the prior-year period — up 44.1% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, EYES's total assets is now $42M (was $29M) — a 44.1% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Second Sight Medical Products is outperforming or lagging.
Tracking EYES's total assets over time shows whether Second Sight Medical Products is scaling, shrinking, or reshaping that part of the business. The current reading is $42M That compares with $29M in the prior-year period — up 44.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this total assets page, Stockcircle has Second Sight Medical Products's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total assets (currently $42M) with ownership activity and broader fundamentals.
Second Sight Medical Products's total assets is $42M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.